SE304513B - - Google Patents

Info

Publication number
SE304513B
SE304513B SE27767A SE27767A SE304513B SE 304513 B SE304513 B SE 304513B SE 27767 A SE27767 A SE 27767A SE 27767 A SE27767 A SE 27767A SE 304513 B SE304513 B SE 304513B
Authority
SE
Sweden
Application number
SE27767A
Inventor
A Gagneux
F Haefliger
C Eugster
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of SE304513B publication Critical patent/SE304513B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE27767A 1963-12-06 1967-01-09 SE304513B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
SE304513B true SE304513B (de) 1968-09-30

Family

ID=4405150

Family Applications (3)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (de) 1963-12-06 1964-12-04
SE27667A SE303507B (de) 1963-12-06 1967-01-09
SE27767A SE304513B (de) 1963-12-06 1967-01-09

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (de) 1963-12-06 1964-12-04
SE27667A SE303507B (de) 1963-12-06 1967-01-09

Country Status (12)

Country Link
US (1) US3242190A (de)
AT (2) AT250348B (de)
BE (1) BE656759A (de)
CH (1) CH427803A (de)
DE (1) DE1445848A1 (de)
DK (4) DK106797C (de)
ES (5) ES306818A1 (de)
FR (2) FR1427775A (de)
GB (1) GB1034939A (de)
IL (1) IL22568A (de)
NL (1) NL6414138A (de)
SE (3) SE301652B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (de) * 1964-09-14
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
JP2004514700A (ja) 2000-11-30 2004-05-20 ファイザー・プロダクツ・インク Gabaアゴニスト及びアルドース還元酵素阻害剤の組み合わせ
OA12534A (en) 2000-11-30 2006-06-05 Pfizer Prod Inc Combination of GABA agonists and sorbitol dehydrogenase inhibitors.
MXPA05012317A (es) * 2003-05-16 2006-01-30 Pfizer Prod Inc Combinaciones terapeuticas de agentes antipsicoticos atipicos con agentes moduladores del gaba anticonvulsivos o benzodiazepinas.
JP5646126B2 (ja) 2003-12-11 2014-12-24 サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. 鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法
WO2005082372A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
AU2006308889A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007104035A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2026813A2 (de) 2006-05-09 2009-02-25 Braincells, Inc. 5-ht-rezeptor-vermittelte neurogenese
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7998971B2 (en) * 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
WO2008036678A2 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Also Published As

Publication number Publication date
ES306817A1 (es) 1965-05-16
ES306818A1 (es) 1965-05-16
IL22568A (en) 1968-04-25
BE656759A (de) 1965-06-08
ES306819A1 (es) 1965-05-16
CH427803A (de) 1967-01-15
GB1034939A (en) 1966-07-06
FR1427775A (fr) 1966-02-11
DK106796C (da) 1967-03-20
AT249054B (de) 1966-09-26
SE301652B (de) 1968-06-17
NL6414138A (de) 1965-06-07
DK106733C (da) 1967-03-13
ES306816A1 (es) 1965-05-16
DK108169C (da) 1967-10-02
DK106797C (da) 1967-03-20
DE1445848A1 (de) 1968-11-21
SE303507B (de) 1968-09-02
US3242190A (en) 1966-03-22
ES306820A1 (es) 1965-05-16
AT250348B (de) 1966-11-10
FR4139M (de) 1966-05-02

Similar Documents

Publication Publication Date Title
AT260747B (de)
BE627012A (de)
BE626938A (de)
BE31062A (de)
BE462764A (de)
BE465565A (de)
BE507458A (de)
BE533484A (de)
BE547422A (de)
BE571209A (de)
BE582314A (de)
BE603935A (de)
BE608372A (de)
BE612803A (de)
BE614220A (de)
BE616247A (de)
BE616830A (de)
BE616967A (de)
BE627025A (de)
BE620325A (de)
BE621232A (de)
BE621517A (de)
BE622160A (de)
BE623117A (de)
BE623220A (de)